𝔖 Bobbio Scriptorium
✦   LIBER   ✦

394 POSTER Final results of a Phase I study of cediranib, a VEGFR signaling inhibitor, in Japanese patients with advanced solid tumors

✍ Scribed by H. Murakami; N. Yamamoto; N. Boku; K. Yamazaki; N. Yamamoto; Y. Yamada; K. Yamada; T. Puchalski; E. Shin; T. Tamura


Book ID
119599550
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
57 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES